Skip to content
★ Sign in to follow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€4,873
▼ Sales (0 ops.)
—

Latest filing published 02 Aug 2022 for MAIA Biotechnology, Inc., €4,873.

Filing timeline

BuySale
Mihail Obrocea

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Mihail Obrocea: trading record in brief

Only one filing by Mihail Obrocea is known so far (2 August 2022): an open-market purchase, €4,873, in MAIA Biotechnology, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Mihail Obrocea

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Medical OfficerExecutivesMAIA Biotechnology, Inc.
    5,000 USD37SEC
    1,000 shares@ US$5.00100.0% of flowCommon StockSEC:0000899243-22-027459:0
    Canonical exit: 30 Oct 2022 (T+90)

1 of 1 declaration